|
As
of December 31, 2023, there were the following potentially dilutive securities that were excluded from diluted net loss per share because
their effect would be anti-dilutive (all shares adjusted to reflect a 40:1 reverse stock split effected on March 9, 2022):
SCHEDULE OF ANTIDILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE
| Shares from common stock options |
|
|
150,611 |
|
| Shares from Telix option fee conversion |
|
|
298,507 |
|
| Shares from the conversion of Series A Stock inclusive of cumulative dividends |
|
|
168,994 |
|
| Shares from the conversion of Series B Preferred Stock inclusive of dividends
(1)
|
|
|
370,661 |
|
| |
|
|
988,773 |
|
| (1) |
Based on conversion price
at December 31, 2023 of $5.30 per share. Pursuant to agreements signed in October 2023 with the Series B Stockholders, upon a listing
of the Company’s stock on Nasdaq or the signing of an agreement to sell or merge the Company, these stockholders will automatically
exchange all of their shares of Series B Stock including accrued dividends through the date of the triggering event at a price of
$3.00 per share. In this instance, the number of potentially dilutive shares as of December 31, 2023 would be 654,696; however as
of the year end, such triggering events had not yet occurred. On February 6, 2024, all Series B shares were exchanged for 658,968
common shares inclusive of dividends through January 31, 2024 (see Note 10 – Subsequent Events). |
As
of December 31, 2022, there were the following potentially dilutive securities that were excluded from diluted net loss per share because
their effect would be anti-dilutive (all shares adjusted to reflect a 40:1 reverse stock split effected on March 9, 2022):
| Shares from common stock options |
|
|
177,815 |
|
| Shares from common stock warrants |
|
|
323,543 |
|
| Shares from the conversion of convertible notes and accrued interest |
|
|
64,126 |
|
| Shares from the conversion of Series A Stock inclusive of cumulative dividends |
|
|
216,577 |
|
| Shares from the conversion of Series B Preferred Stock inclusive of dividends |
|
|
292,990 |
|
| |
|
|
1,075,051 |
|
|